Skip to main navigation Skip to search Skip to main content

Torsades de pointes associated with methadone and voriconazole

  • Jennifer A. Reinhold
  • , Cynthia A. Sanoski
  • , Andrea M. Russo
  • , Joshua M. Cooper
  • , Sarah A. Spinler
  • University of Sciences in Philadelphia
  • Thomas Jefferson University
  • Cooper University Health Care
  • University of Pennsylvania

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

This report concerns a case of torsades de pointes (TdP) associated with the concomitant administration of methadone and voriconazole in a patient with comorbid medical conditions. A 57-year-old man, with a medical history of human immunodeficiency virus, infective endocarditis, hepatitis C and orbital Aspergillus infection, was admitted to the intensive care unit following several episodes of TdP. The patient was being treated with methadone for opioid addiction and had started taking voriconazole 2 weeks prior for orbital Aspergillosis. He experienced multiple episodes of TdP with a prolonged QTc interval (>600 ms). The pronounced inhibitory impact of voriconazole on methadone metabolism via the cytochrome P450 (CYP)2B6 isoenzyme was identified as a probable cause of the arrhythmia. Voriconazole was subsequently temporarily withheld and the methadone dose was significantly reduced. The patient received an implantable cardioverter-defibrillator, did not experience additional episodes of TdP during hospitalisation, and was discharged from the hospital on day 13.

Original languageEnglish
JournalBMJ Case Reports
DOIs
StatePublished - Dec 22 2009

Fingerprint

Dive into the research topics of 'Torsades de pointes associated with methadone and voriconazole'. Together they form a unique fingerprint.

Cite this